Stock comparison
ADMA Biologics
ADMA$2.04BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$71.86BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
ADMA 16 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ADMA1wins
6winsJSLL.BO
48D
B84
55D
A87
59D
A92
82B
C66
46D
B75
58D
A91
51D
A95
Side-by-side metrics
| Metric | ADMA | JSLL.BO |
|---|---|---|
| Market cap | $2.04B | $71.86B Winner |
| P/E (TTM) | Winner: 12.0x | 33.2x |
| EV/EBIT | Winner: 10.5x | 24.1x |
| ROIC (TTM) | 27.81% | 39.15% Winner |
| Gross margin | 61.27% | 88.58% Winner |
| Net margin | Winner: 32.43% | 27.68% |
| Revenue CAGR 5y | Winner: 58.45% | 57.81% |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | 0.5x | 0.3x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ADMA leads on
- P/E (TTM)12.0xvs 33.2x+64%
- EV/EBIT10.5xvs 24.1x+56%
- Net margin32.43%vs 27.68%+15%
JSLL.BO leads on
- Market cap$71.86Bvs $2.04B+97%
- Debt / Equity0.3xvs 0.5x+48%
- Gross margin88.58%vs 61.27%+31%
- ROIC (TTM)39.15%vs 27.81%+29%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.